Mono Femara 2.5 mg 50 Tablets (Beligas Pharma) – Letrozole Oral

Product Description:

Mono Femara by Beligas Pharma contains Letrozole, a powerful oral aromatase inhibitor (AI) primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Each pack includes 50 tablets of 2.5 mg.

Letrozole works by reducing estrogen production in the body, which helps slow or stop the growth of estrogen-dependent breast cancer cells. In addition, Letrozole has clinical applications in fertility treatments for women with ovulation issues, making it a versatile oral medication.

Key Features

• Manufacturer: Beligas Pharma

• Active Ingredient: Letrozole

• Strength: 2.5 mg per tablet

• Pack Size: 50 tablets

• Form: Oral tablets

• Category: Aromatase inhibitor (AI) / Hormonal therapy

How Letrozole Works

• Inhibits the enzyme aromatase, responsible for converting androgens into estrogens

• Significantly lowers circulating estrogen levels in the body

• Slows the growth of hormone receptor-positive breast cancers

• Supports ovulation induction in fertility treatments for women

Uses & Benefits of Femara (Letrozole)

• Effective in breast cancer treatment and prevention of recurrence

• Reduces the risk of cancer spreading to other parts of the body

• Used off-label for fertility treatment in women with ovulation problems

• Provides support in hormone-sensitive conditions

Dosage & Administration

• Typical Dosage: 2.5 mg tablet taken once daily

• Administration: With or without food, at the same time each day

• Treatment Length: Determined by physician based on medical condition and response

• Fertility Use: Dose and protocol adjusted under medical supervision

Possible Side Effects of Letrozole

Like all hormonal therapies, Letrozole may cause side effects, including:

• Bone weakening / osteoporosis (due to reduced estrogen)

• Hot flashes and sweating (including night sweats)

• Joint or bone pain

• Fatigue and weakness

• Headaches, nausea, or constipation

• Hair thinning or hair loss

• Vaginal bleeding or breast pain

• Weight fluctuations and loss of appetite

Who Should Avoid Letrozole?

• Women who have not completed menopause

• Pregnant or breastfeeding women

• Individuals with severe liver disease

• Patients with osteoporosis or high cholesterol (without medical monitoring)

• Those already taking other breast cancer or infertility medications